Literature DB >> 25922273

Indications, techniques, outcomes, and limitations for minimally ischemic and off-clamp partial nephrectomy: a systematic review of the literature.

Giuseppe Simone1, Inderbir S Gill2, Alexandre Mottrie3, Alexander Kutikov4, Jean-Jacques Patard5, Antonio Alcaraz6, Craig G Rogers7.   

Abstract

CONTEXT: On-clamp partial nephrectomy (PN) has been considered the standard approach to minimize intraoperative bleeding and thus achieve adequate control of tumor margins. The potential negative impact of ischemia on renal function (RF) led to the development of techniques to minimize or avoid renal ischemia, such as off-clamp PN and minimally ischemic PN techniques.
OBJECTIVE: To review current evidence on the indications and techniques for and outcomes of minimally ischemic and off-clamp PN. EVIDENCE ACQUISITION: A systematic review of English-language publications on PN without a main renal artery clamp from January 2005 to July 2014 was performed using the Medline, Embase, and Web of Science databases. EVIDENCE SYNTHESIS: The searches retrieved 52 papers. Off-clamp PN has been more commonly applied to small and peripheral renal tumors, while minimally ischemic PN is best suited for hilar and medially located renal tumors. These approaches are associated with increased intraoperative blood loss and perioperative transfusion rates compared to on-clamp PN. Minimally ischemic and off-clamp PN have potential functional benefits when longer ischemia time is anticipated, particularly for patients with lower baseline RF. Limitations include the lack of prospective randomized trials comparing minimally ischemic and off-clamp to on-clamp techniques, and the small sample size and short follow-up of most published series. The impact of different resection and renorrhaphy techniques on postoperative RF and its assessment via renal scintigraphy requires further investigations.
CONCLUSIONS: Minimally ischemic and off-clamp PN are established procedures that may be particularly applicable for patients with decreased baseline RF. However, these techniques are technically demanding, with potential for increased blood loss, and require considerable experience with PN surgery. The role of ischemia in patients with a contralateral healthy kidney and consequently an indication for elective minimally ischemic or off-clamp PN remains a debatable issue. PATIENT
SUMMARY: In this review we analyzed available evidence on minimally ischemic and off-clamp partial nephrectomy. These techniques, although technically demanding, may be particularly applicable for patients with decreased baseline renal function.
Copyright © 2015 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clampless; Ischemia; Off-clamp; Parenchymal clamp; Partial nephrectomy; Segmental clamp; Selective clamp; Unclamped; Zero-ischemia

Mesh:

Year:  2015        PMID: 25922273     DOI: 10.1016/j.eururo.2015.04.020

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  28 in total

Review 1.  Zero ischaemia partial nephrectomy: a call for standardized nomenclature and functional outcomes.

Authors:  Ahmad Alenezi; Giacomo Novara; Alexander Mottrie; Salah Al-Buheissi; Omer Karim
Journal:  Nat Rev Urol       Date:  2016-10-18       Impact factor: 14.432

Review 2.  Surgical and Minimally Invasive Therapies for the Management of the Small Renal Mass.

Authors:  John Withington; Joana B Neves; Ravi Barod
Journal:  Curr Urol Rep       Date:  2017-08       Impact factor: 3.092

3.  Accuracy of magnetic resonance imaging to identify pseudocapsule invasion in renal tumors.

Authors:  Rocco Papalia; Valeria Panebianco; Riccardo Mastroianni; Maurizio Del Monte; Emanuela Altobelli; Eliodoro Faiella; Francesco Rosario Grasso; Mariangela Bellangino; Giuseppe Simone; Massimo Ciccozzi; Silvia Angeletti; Giulia D'ovidio; Carlo Catalano; Michele Gallucci; Roberto Mario Scarpa; Giovanni Muto
Journal:  World J Urol       Date:  2019-04-25       Impact factor: 4.226

4.  Predicting biological behaviour of newly diagnosed renal masses: a possible role of cell proliferation biomarkers?

Authors:  Riccardo Mastroianni; Aldo Brassetti; Manuela Costantini; Giuseppe Simone
Journal:  Ann Transl Med       Date:  2019-07

5.  The zero ischemia index (ZII): a novel criterion for predicting complexity and outcomes of off-clamp partial nephrectomy.

Authors:  Yaohui Li; Lin Zhou; Tingchang Bian; Zhuoyi Xiang; Yeqing Xu; Yanjun Zhu; Xiaoyi Hu; Shuai Jiang; Jianming Guo; Hang Wang
Journal:  World J Urol       Date:  2016-11-24       Impact factor: 4.226

6.  Margin and complication rates in clampless partial nephrectomy: a comparison of open, laparoscopic and robotic surgeries.

Authors:  Luigi Mearini; Elisabetta Nunzi; Alberto Vianello; Manuel Di Biase; Massimo Porena
Journal:  J Robot Surg       Date:  2016-04-15

7.  Comparison of renal functional outcomes in exactly matched pairs between robot-assisted partial nephrectomy using warm ischemia and open partial nephrectomy using cold ischemia using diethylene triamine penta-acetic acid renal scintigraphy.

Authors:  Sangjun Yoo; Chanwoo Lee; Chunwoo Lee; Dalsan You; In Gab Jeong; Choung-Soo Kim
Journal:  Int Urol Nephrol       Date:  2016-02-20       Impact factor: 2.370

Review 8.  Periarterial papaverine to treat renal artery vasospasm during robot-assisted laparoscopic partial nephrectomy.

Authors:  Igor Sorokin; Sharnae L Stevens; Jeffrey A Cadeddu
Journal:  J Robot Surg       Date:  2017-04-28

9.  Ipsilateral renal function preservation following minimally invasive partial nephrectomy: The effect of tumour characteristics and warm ischemic time.

Authors:  Ernest Chan; Shawna L Boyle; Jeffrey Campbell; Patrick P W Luke
Journal:  Can Urol Assoc J       Date:  2017-10       Impact factor: 1.862

10.  Early clamp release during laparoscopic partial nephrectomy: Implications for preservation of renal function.

Authors:  Jeffrey Campbell; Garson Chan; Patrick P Luke
Journal:  Can Urol Assoc J       Date:  2017-07-11       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.